The Prometheus League
Breaking News and Updates
- Abolition Of Work
- Ai
- Alt-right
- Alternative Medicine
- Antifa
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ascension
- Astronomy
- Atheism
- Atheist
- Atlas Shrugged
- Automation
- Ayn Rand
- Bahamas
- Bankruptcy
- Basic Income Guarantee
- Big Tech
- Bitcoin
- Black Lives Matter
- Blackjack
- Boca Chica Texas
- Brexit
- Caribbean
- Casino
- Casino Affiliate
- Cbd Oil
- Censorship
- Cf
- Chess Engines
- Childfree
- Cloning
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Covid-19
- Cryonics
- Cryptocurrency
- Cyberpunk
- Darwinism
- Democrat
- Designer Babies
- DNA
- Donald Trump
- Eczema
- Elon Musk
- Entheogens
- Ethical Egoism
- Eugenic Concepts
- Eugenics
- Euthanasia
- Evolution
- Extropian
- Extropianism
- Extropy
- Fake News
- Federalism
- Federalist
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom
- Freedom of Speech
- Futurism
- Futurist
- Gambling
- Gene Medicine
- Genetic Engineering
- Genome
- Germ Warfare
- Golden Rule
- Government Oppression
- Hedonism
- High Seas
- History
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Immortality
- Human Longevity
- Illuminati
- Immortality
- Immortality Medicine
- Intentional Communities
- Jacinda Ardern
- Jitsi
- Jordan Peterson
- Las Vegas
- Liberal
- Libertarian
- Libertarianism
- Liberty
- Life Extension
- Macau
- Marie Byrd Land
- Mars
- Mars Colonization
- Mars Colony
- Memetics
- Micronations
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- Nanotech
- National Vanguard
- NATO
- Neo-eugenics
- Neurohacking
- Neurotechnology
- New Utopia
- New Zealand
- Nihilism
- Nootropics
- NSA
- Oceania
- Offshore
- Olympics
- Online Casino
- Online Gambling
- Pantheism
- Personal Empowerment
- Poker
- Political Correctness
- Politically Incorrect
- Polygamy
- Populism
- Post Human
- Post Humanism
- Posthuman
- Posthumanism
- Private Islands
- Progress
- Proud Boys
- Psoriasis
- Psychedelics
- Putin
- Quantum Computing
- Quantum Physics
- Rationalism
- Republican
- Resource Based Economy
- Robotics
- Rockall
- Ron Paul
- Roulette
- Russia
- Sealand
- Seasteading
- Second Amendment
- Second Amendment
- Seychelles
- Singularitarianism
- Singularity
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Spacex
- Sports Betting
- Sportsbook
- Superintelligence
- Survivalism
- Talmud
- Technology
- Teilhard De Charden
- Terraforming Mars
- The Singularity
- Tms
- Tor Browser
- Trance
- Transhuman
- Transhuman News
- Transhumanism
- Transhumanist
- Transtopian
- Transtopianism
- Ukraine
- Uncategorized
- Vaping
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Waveland
- Ww3
- Yahoo
- Zeitgeist Movement
-
Prometheism
-
Forbidden Fruit
-
The Evolutionary Perspective
Daily Archives: October 15, 2012
Einstein establishes the Paul F. Glenn Center for the Biology of Human Aging Research
Posted: October 15, 2012 at 10:20 pm
Public release date: 15-Oct-2012 [ | E-mail | Share ]
Contact: Kim Newman sciencenews@einstein.yu.edu 718-430-3101 Albert Einstein College of Medicine
October 15, 2012 (BRONX, NY) Albert Einstein College of Medicine of Yeshiva University has received a $3 million grant from the Glenn Foundation for Medical Research to establish the Paul F. Glenn Center for the Biology of Human Aging Research. The grant will fund research to translate recent laboratory and animal discoveries into therapies to slow human aging.
Aging contributes to many of the debilitating and costly diseases including cancer, cardiovascular disease and diabetes that burden the United States and many other countries. This complex but universal condition causes individual cells and the body as a whole to decline in function. Finding the mechanisms that underlie the aging process may lead to treatments that slow aging, prevent or limit common diseases, and allow people to live healthier, longer lives.
"Unless we find protective mechanisms to delay aging, we will not make progress against age-related diseases," said Nir Barzilai, M.D., co-director of the new center as well as director of the Institute for Aging Research, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and professor of medicine and of genetics at Einstein. "With this valuable grant from the Paul F. Glenn Foundation, we hope to make significant advances toward understanding the aging process and improving human health."
"The generosity of Paul F. Glenn and his foundation is a welcome shot in the arm for aging research in the United States, which is chronically underfunded," said Jan Vijg, Ph.D., co-director of the new center, the Lola and Saul Kramer Chair in Molecular Genetics, and professor and chair of genetics and professor of ophthalmology and visual sciences at Einstein. "This grant will help Einstein to maintain its position as one of the world's leaders in this rapidly growing field."
"Paul F. Glenn has been a visionary in aging research for more than 30 years," said Ana Maria Cuervo, M.D., Ph.D., co-director of the new center, the Robert and Rene Belfer Chair for the Study of Neurodegenerative Diseases, and professor of developmental and molecular biology, of anatomy and structural biology and of medicine at Einstein. "Some of us got to know him when we were still graduate students and he came to scientific conferences to see the data as it was being developed. Paul's personal approach to science has made a big difference to many of us in the field of aging research and has contributed to the career development of many young investigators."
The funding, in the form of pilot and feasibility study grants, is targeted to several specific research projects: uncovering the genetic and epigenetic mechanisms that protect humans against aging and age-related diseases, testing the effectiveness of the first-generation pro-longevity therapies, and developing novel preventive and therapeutic interventions against cellular aging in humans.
###
Drs. Barzilai and Cuervo are also co-directors of Einstein's Institute for Aging Research and, together with Dr. Vijg, of the Nathan Shock Center for the Basic Biology of Aging. Both centers are funded by the National Aging Institute, part of the National Institutes for Health.
Go here to see the original:
Einstein establishes the Paul F. Glenn Center for the Biology of Human Aging Research
Posted in Human Longevity
Comments Off on Einstein establishes the Paul F. Glenn Center for the Biology of Human Aging Research
Human Life Span Took Huge Jump in Past Century
Posted: at 10:20 pm
Humans are living longer than ever, a life-span extension that occurred more rapidly than expected and almost solely from environmental improvements as opposed to genetics, researchers said today (Oct. 15).
Four generations ago, the average Swede had the same probability of dying as a hunter-gatherer, but improvements in our living conditions through medicine, better sanitation and clean drinking water (considered "environmental" changes) accelerated life spans to modern levels in just 100 years, researchers found.
In Japan, 72 has become the new 30, as the likelihood of a 72-year-old modern-day person dying is the same as a 30-year-old hunter-gatherer ancestor who lived 1.3 million years ago. Though the researchers didn't specifically look at the United States, they say the life-span trends are not country-specific and not based in genetics.
Quick jump in life span
The same progress of decreasing average probability of dying at a certain age in hunters-gatherers that took 1.3 million years to achieve was made in 30 years during the 21st century.
"I pictured a more gradual transition from a hunter-gatherer mortality profile to something like we have today, rather than this big jump, most of which occurred in the last four generations, to me that was surprise," lead author Oskar Burger, postdoctoral fellow at the Max Planck Institute for Demographic Research in Germany, told LiveScience.
Biologists have lengthened life spans of worms, fruit flies and mice in labs by selectively breeding for old-age survivorship or tweaking their endocrine system, a network of glands that affects every cell in the body. However, the longevity gained in humans over the past four generations is even greater than can be created in labs, researchers concluded. [Extending Life: 7 Ways to Live Past 100]
Genetics vs. environment
In the new work, Burger and colleagues analyzed previously published mortality data from Sweden, France and Japan, from present-day hunter-gatherers and from wild chimpanzees, the closet living relative to humans.
Humans have lived for an estimated 8,000 generations, but only in the past four have mortalities increased to modern-day levels. Hunter-gatherers today have average life spans on par with wild chimpanzees.
See the original post here:
Human Life Span Took Huge Jump in Past Century
Posted in Human Longevity
Comments Off on Human Life Span Took Huge Jump in Past Century
Living longer comes easier
Posted: at 10:20 pm
Despite what the fashion magazines tell you, 40 isnt the new 30. Seventy is.
A new study finds that humans are living so much longer today compared with the rest of human history that the probability of dying at 72 is similar to the death odds our ancestors likely faced at 30.
This uptick in longevity is quite recent occurring in the last century and a half which suggests it has little to do with genes, starvation diets or anti-aging miracle drugs. Rather, it is likely due to eliminating environmental dangers faced by Homo sapiens of old, an evolutionary anthropologist and his colleagues argue online October 15 in the Proceedings of the National Academy of Sciences. Sanitation measures that clean up drinking water, regular access to food, plus antibiotics and vaccines seem to go a long way toward fighting off death.
Its striking, says Ronald Lee, an economist at the University of California, Berkeley who specializes in demographics and aging. We already think of humans as a really long-lived species, says Lee, who wasnt involved in the study. It raises the question of how far we can go.
Evolutionary anthropologist Oskar Burger and his team wanted to study human longevity in an evolutionary context. So they turned to previously gathered data on chimpanzees, hunter-gatherer societies in parts of Africa and South America and numbers from the Human Mortality Database for Japan, Sweden and France.
The data reveal a steady, gradual drop in the probability of dying relatively young that begins just before 1900 for the French and Swedes. But the mortality numbers for hunter-gatherers remain closer to wild chimpanzees than to these westernized societies. However, when the researchers looked at hunter-gatherer groups who received some western medicine and occasional help with food, the mortality in those groups dropped, widening the gap between them and chimps and bumping them up to numbers comparable with pre-1900 Sweden and France.
Its amazing what clean water and a bit of extra food gets you, says Berger, of the Max Planck Institute for Demographic Research in Rostock, Germany.
A 30-year-old hunter-gatherer has the same probability of death as a Japanese person today who is 72 years old, the study found. At 15, a hunter-gatherer has a 1.3 percent probability of dying in the next year; Swedes hit those odds at age 69.
Surprisingly, the research also suggests that theres room for improvement, and that the upper limit on healthy human living has yet to be reached. Aging theory suggests that the biological machinery should increasingly break down once a person passes the age of reproducing and caring for young (SN: 10/20/12, p. 16). But for some reason, humans seem to have become exceptionally good at dodging that bullet.
And researchers may even be able to extend human lifespans even longer with insights from ongoing research into the cellular switches and genes that extend the lives of roundworms and rodents in the lab.
Continued here:
Living longer comes easier
Posted in Human Longevity
Comments Off on Living longer comes easier
Idera Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2 Trial of IMO-3100 in Patients with Psoriasis
Posted: at 10:20 pm
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases. Idera anticipates top-line data from this study will be available by year-end 2012. TLRs are a class of proteins that play a key role in both inflammation and immunity. Through the inhibition of specific TLRs, Ideras candidates may represent a novel approach for the treatment of psoriasis, lupus and other autoimmune diseases.
In this Phase 2 proof-of-concept study, we are evaluating multiple endpoints to assess the clinical activity of IMO-3100, including the impact on Psoriasis Area Severity Index (PASI), mean focal psoriasis severity, and Physician Global Assessment (PGA) scores, said Dr. Robert Arbeit, Vice President of Clinical Development at Idera. In addition to the clinical assessments, we are evaluating biopsies of psoriasis plaques for treatment-related changes in epidermal thickness and immune cell infiltrates consistent with the intended mechanism of action.
We have made significant progress in advancing our autoimmune disease program, including the completion of enrollment in the Phase 2 trial of IMO-3100 in patients with psoriasis. said Dr. Sudhir Agrawal, Chief Executive Officer of Idera. In addition, our investigational new drug (IND) application for IMO-8400, a lead candidate for lupus, is now active. We expect our phase 2 study of IMO-3100 and planned clinical trials of IMO-8400 will help us to establish the benefits of inhibiting Toll-like Receptor-mediated pathways, which include controlling the induction of multiple cytokines, such as TNF-, IL-12, IL-6, and IL-17, as well as downstream signaling. We look forward to reporting top-line data from the Phase 2 study of IMO-3100 in psoriasis and initiating clinical development of IMO-8400 before the end of 2012.
Idera also announced today that its Investigational New Drug application for IMO-8400 with the US Food and Drug Administration is now active. IMO-8400, an antagonist of TLRs 7, 8, and 9, is Ideras second lead candidate for use in treating autoimmune diseases, with lupus selected as an initial indication for clinical development. Idera anticipates initiating a Phase 1 dose escalation trial during the fourth quarter of 2012 to evaluate the safety and pharmacodynamics of IMO-8400 in healthy subjects. Following successful completion of the Phase 1 study, Idera expects to initiate a Phase 2 clinical trial of IMO-8400 in patients with lupus.
Recent and Upcoming Autoimmune Disease Program Milestones
Fourth Quarter 2012:
Year 2013:
About TLRs and Idera's Pipeline
Toll-like Receptors (TLRs) play a key role in inflammation and immunity. Of the 10 human TLRs identified to date, Idera is developing compounds targeted to TLRs 3, 7, 8, and 9, which are expressed in different cells and serve unique functions. Using its chemistry-based approach, Idera has created novel drug candidates that modulate immune responses through either activation or inhibition of specific TLRs. Inhibition of specific TLRs may be useful in treating autoimmune disorders, such as systemic lupus erythematosus (SLE), psoriasis, and rheumatoid arthritis, by blocking the induction of multiple cytokines and signaling pathways. Idera's lead clinical candidates for application in autoimmune diseases are IMO-3100, an antagonist of TLR7 and TLR9, and IMO-8400, an antagonist of TLRs 7, 8, and 9.
See the original post here:
Idera Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2 Trial of IMO-3100 in Patients with Psoriasis
Posted in Psoriasis
Comments Off on Idera Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2 Trial of IMO-3100 in Patients with Psoriasis
People with severe psoriasis nearly twice at risk for diabetes
Posted: at 10:20 pm
ScienceDaily (Oct. 15, 2012) An analysis of 27 studies linking psoriasis in 314,000 individuals with diabetes has found strong correlation between the scaly skin rash and the blood sugar disorder that predisposes patients to heart disease, say UC Davis researchers who led the review.
The findings appear in the Archives of Dermatology.
"Our investigation found a clear association between psoriasis and diabetes," said April Armstrong, assistant professor of dermatology at UC Davis and principal investigator of the study. "Patients with psoriasis and their physicians need to be aware of the increased risk of developing diabetes so that patients can be screened regularly and benefit from early treatment."
Psoriasis is a common skin problem that tends to run in families. It causes a raised red, flaky and sometimes itchy rash, often on the elbows and knees, although it can appear anywhere. It is believed to be an autoimmune disease, in which the body regards its own skin as foreign and mounts an inflammatory response.
Armstrong and her colleagues combined data from 27 observational studies of patients with psoriasis, in what is known as a meta-analysis. Five of the studies assessed the incidence of diabetes -- that is, how many patients with psoriasis developed diabetes during the course of a study, which ranged from 10 to 22 years. The other studies assessed the prevalence of diabetes -- how many patients already had diabetes at the outset of a study. Altogether, the studies evaluated more than 314,000 people with psoriasis and compared them to 3.7 million individuals (controls) without the disease.
Some of the studies classified patients by disease severity. The aggregate data for these studies showed that patients with mild psoriasis are over 1.5 times more likely to have diabetes than the general population while those with severe disease are nearly twice as likely. Among studies that assessed incidence, patients with psoriasis had a 27 percent increased risk of developing diabetes compared with the general population.
All but one study analyzing incidence found a link between psoriasis and diabetes. These studies included patient data from outpatient clinics, insurance claims and hospitals. Diabetes rates were similar in patients despite ethnicity or country where the study was conducted.
"The large sample size and consistent association between psoriasis and diabetes make these study findings very strong and suggest an underlying physiological link between the two diseases," said Armstrong, who directs the Dermatology Clinical Research Unit at UC Davis and the teledermatology program.
While additional research is need to understand how the two diseases are associated, Armstrong believes altered immune pathways may make psoriasis patients more susceptible to developing diabetes.
"There is evidence that fat cells in psoriasis patients may not function normally," she said. "These cells secrete inflammatory substances known as cytokines that increase insulin resistance in the liver and muscle and initiate destruction of insulin-producing cells in the pancreas."
Excerpt from:
People with severe psoriasis nearly twice at risk for diabetes
Posted in Psoriasis
Comments Off on People with severe psoriasis nearly twice at risk for diabetes
Additive effect of small gene variations can increase risk of autism spectrum disorders
Posted: at 10:20 pm
Public release date: 15-Oct-2012 [ | E-mail | Share ]
Contact: Anita Srikameswaran 412-578-9193 University of Pittsburgh Schools of the Health Sciences
PITTSBURGH, Oct. 15, 2012 An increased risk of autism spectrum disorders (ASD) could result from an accumulation of many small, common genetic variations rather than large-effect, rare changes in the genetic code, according to a multicenter team led by researchers at the University of Pittsburgh School of Medicine. Their findings, published today in Molecular Autism, provide new insights into the genetic factors that underlie the neurodevelopmental condition.
Scientists have debated about the genetic contributions that lead to ASD in families where only one individual is affected, called simplex, versus those that have multiple affected family members, called multiplex, said senior author Bernie Devlin, Ph.D., associate professor, Department of Psychiatry, University of Pittsburgh School of Medicine.
"Our team compared simplex, multiplex and unaffected families using sophisticated quantitative genetic techniques," he said. "In families where only one child has an ASD, 40 percent of the risk is inherited while in families with more than one affected child, the risk rises to 60 percent."
For the project, the team examined thousands of DNA samples from families in the Simons Simplex Collection, in which one child but no parent or sibling had an ASD; the Autism Genome Project, in which more than one child had an ASD; and unaffected families enrolled in the HealthABC Program.
In addition to reviewing nearly 1 million gene variations, called single nucleotide polymorphisms (SNPs), to look for inheritance patterns associated with ASD, they also ran computer simulations to plot family trees using 1,000 SNPs that appear to impact the risk of ASD.
"These small gene changes can add up even though individually they do little harm," Dr. Devlin said. "This might explain why parents who do not have autism traits can have children who do."
Other research has shown that autism and related disorders also can arise from spontaneous variations in parental genes prior to conception as well as rare mutations of larger effect that are passed on, he noted. The multiple inheritance patterns could help explain the range of symptoms in the disorder.
The team included researchers from Yale University, the University of Michigan, University of California Los Angeles, Emory University, Harvard University and others. The effort was funded by grants from the Simons Foundation and National Institutes of Health grant MH057881.
Go here to see the original:
Additive effect of small gene variations can increase risk of autism spectrum disorders
Posted in Gene Medicine
Comments Off on Additive effect of small gene variations can increase risk of autism spectrum disorders
Ron Paul: 22.8% Real Unemployment! – Video
Posted: at 10:19 pm
15-10-2012 13:59 -Please like, share, subscribe & comment! Facebook Backup YouTube channel: Email updates: 10 Ron Paul is America's leading voice for limited, constitutional government, low taxes, free markets, sound money, and a pro-America foreign policy. To spread the message, visit and promote the following websites: (grassroots website) http (Ron Paul in Congress) (discussion forum) Disclaimer This video is not-for-profit clip that is uploaded for the purpose of education, teaching, and research, which falls under fair use according to the Copyright Act of 1976 and tips the balance in favor of fair use; all intellectual content within the video remains property of its respective owners.
Originally posted here:
Ron Paul: 22.8% Real Unemployment! - Video
Posted in Ron Paul
Comments Off on Ron Paul: 22.8% Real Unemployment! – Video
Ron Paul backs Ted Yoho
Posted: at 10:19 pm
U.S. Rep. Ron Paul has endorsed GOP congressional candidate Ted Yoho.
"I endorse Ted Yoho for Florida's 3rd District. His commitment to the Constitution and individual liberties is exactly what we need more of in the House," Paul said in a release.
Yoho, who defeated 12-term incumbent Cliff Stearns, is running for a seat that runs from the Gulf of Mexico to Clay County. He is facing Democrat JR Gaillot, a Clay County political consultant.
Here is the full release:
Leader of the liberty movement, Congressman Ron Paul of Texas has endorsed Dr. Ted Yoho, Republican nominee for North Central Floridas 3rd Congressional District. Ted Yoho is one of 11 House candidates across the United States to be endorsed by Ron Paul.
I endorse Ted Yoho for Floridas 3rd District. His commitment to the Constitution and individual liberties is exactly what we need more of in the House, said Congressman Paul.
Yoho thanked Dr. Paul for his support.
Im incredibly humbled that the leader of the modern liberty movement and strong conservative leader Congressman Ron Paul is backing our campaign. I admire Congressman Paul for his relentless pursuit of conservative values, his passion for our Constitution and our great Republic. Yoho said. I hope that I can continue to champion Dr. Pauls efforts to audit the Fed, protect States rights and getting our Nation back on track.
Dr. Yoho is a conservative business man and large animal veterinarian who has lived in north central Florida for the last 35 years. The seat Dr. Yoho is seeking is the newly created Congressional District 3 which encompasses the following counties: Alachua, Gilchrist, Levy, Dixie, Lafayette, Suwannee, Columbia, Bradford, Union, Hamilton, Clay, the eastern portion of Madison and the north western portion of Marion County.
For more information about Dr. Yoho, please visit http://www.tedyoho.com
See more here:
Ron Paul backs Ted Yoho
Posted in Ron Paul
Comments Off on Ron Paul backs Ted Yoho
Anonymity and its limits: Reddit v Gawker
Posted: at 10:19 pm
Freedom is rarely absolute. Yelling fire in a crowded movie theatre, expressing your religion by killing people - everything has a limit. I'm generally a fan of anonymity online. I like that anyone can be anyone, it's often hilarious, and it encourages conversation free of pretence. The freedom to remain anonymous has a limit, however: when you post a bomb threat or creepy photos of women without telling them.
You might have heard about this controversy over the past few days. Basically, Gawker threatened (and followed through) uncovering the real identity of a notorious Reddit troll, and some Redditors threatened to release the real names of /r/creepshots mods. Creepshots was a forum for posting covert sexual pictures of women unaware that they were being photographed.
Many on Reddit got pretty mad - Gawker was banned from the site for a time. Creepshots was voluntarily banned, the mods scared off by the possibility of their real-life details being released. You see, revealing personal details is against the rules of Reddit - who take being a neutral platform/freedom of speech very seriously. The backlash from many in the Reddit community has been strong - anonymity is important to many - and the fear is that exposing users' details will now become the norm with any conflict. I understand this fear - but I think it is unfounded.
A lot of people have posted stuff anonymously that they would be horrified to have released to the public. That is totally fine. There is a line that we should all be able to understand here. Ninety-nine per cent of anonymous discussion deserves to remain that way - weird fetishes, fringe political views, gossip - but creepshots of other people is over the line. We all accept that child porn is over the line, so we are obviously fine with not being absolutists. Creepshots aren't just something that people find icky - think MLP porn or libertarianism - it directly victimises people.
I've never been a "witchhunt the pedos" kinda guy, but if this is what it took for them to shut down Creepshots then so be it. The ones threatening the release of names weren't chasing down a guy who hasn't offended in years, they were trying to stop something that was happening every day. Freedom of speech does not mean freedom to distribute sexualised photos of strangers, but I think you could make a pretty good case for it covering the name of a creepshot mod. I can understand a variance of opinion with the release of names though; I just think Creepshots should have been shut down by Reddit itself months ago. I'm sure there is someone who works there whom most of the community could trust to draw a line between "distasteful" and "horrific".I wouldn't want everything I have ever posted in various anonymous places revealed at all, but there is a difference between stupid stuff I said when I was 15 and something like creepshots.What do y'all think?
Email Henry or follow him on Twitter.
See the rest here:
Anonymity and its limits: Reddit v Gawker
Posted in Libertarianism
Comments Off on Anonymity and its limits: Reddit v Gawker
Libya names human-rights lawyer Ali Zidan as interim prime minister
Posted: at 10:19 pm
TRIPOLI, LibyaLibya's Congress elected a human-rights lawyer as interim prime minister Sunday, a week after his predecessor was sacked for failing to present a Cabinet lineup that political factions could agree on.
Ali Zidan, also a former independent congressman, won 93 votes, securing a majority of those who voted in a poll to determine the country's leader for a transitional period of about 20 months.
Zidan's top priority will be to name a new government that congress approves. The Cabinet will be faced with the daunting task of disarming thousands of young men who fought in last year's eight-month civil war that led to the capture and killing of longtime dictator Moammar Khadafy.
The ministers will also be pressed to provide basic services, restore security by creating a military and police force capable of asserting authority over disparate militias left over from the war, and unifying the country's tribes and towns.
One such militia, a radical Islamist group that now claims to have dissolved, has been linked to the attack last month on the U.S. Consulate in the eastern city of Benghazi that killed American Ambassador Chris Stevens and three others.
Any prime minister who wants to impose his authority on the militias will need broad national support for his government but such support is hard to obtain.
The 200-member congress selected Zidan after last week's dismissal of Mustafa Abushagur after just 25 days in the post for failing to present a Cabinet list that satisfied legislators.
Zidan was a diplomat under Khadafy before defecting in the 1980s and joining Libya's oldest opposition movement, National Front for the Salvation of Libya, from Geneva where he lived. On Sunday, he edged out Minister for Local Government Mohammed Al-Harari by eight votes.
See the original post:
Libya names human-rights lawyer Ali Zidan as interim prime minister
Posted in Post Human
Comments Off on Libya names human-rights lawyer Ali Zidan as interim prime minister